Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
NCT ID: NCT05546138
Last Updated: 2024-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2023-10-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
NCT01847937
Corneal Confocal Microscopy to Detect Diabetic Neuropathy in Children
NCT02321904
NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes
NCT01707979
A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes
NCT01822431
Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
NCT02423434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Diabetic peripheral neuropathy is the most common complication to diabetes mellitus affecting as much as 50% of the population with diabetes. Symmetrical sensory neuropathy is by far the most common pattern, which often progress slowly over many years, although some individuals experience faster and more severe courses. Despite the frequent occurrence, the causes of diabetic peripheral neuropathy are largely unknown, which is reflected in the fact that no disease-modifying treatments are available for preventing, treating or even halting the progression of the disease. The consequences can be dire, as neuropathy frequently leads to foot ulcers, amputations or intolerable neuropathic pain in the lower extremities. Sensory loss may go completely undetected in diabetes, as there often are literally no symptoms. For many individuals, the development of diabetic peripheral neuropathy can therefore proceed completely unnoticed, making regular screening the most important tool for diagnosing the condition. Unfortunately, unlike nephropathy or retinopathy, diabetic peripheral neuropathy is not easily screened for, as the condition lacks reliable markers for early- or progressing disease. Therefore, screening for diabetic peripheral neuropathy currently revolves around diagnosing loss of protective sensation, judged by the inability to feel vibration or light touch. However, in their most recent guidelines, the American Diabetes Association has included screening for small fibre neuropathy using either the cold- and heat perception thresholds or pinprick as a clinical standard. Although this acknowledgement of the importance of assessing not only large- but also small nerve fibres is a huge step towards early detection of diabetic peripheral neuropathy, the overriding issue of insensitive, unreproducible, and inaccurate bedside tests for small nerve fibres remains. While cold- and heat perception and pinprick sensation are indeed mediated by small nerve fibres, the sensitivity of these methods, outside of extreme standardization only achievable in dedicated neuropathy research-centres, remain poor and not usable on an individual level. This lack of sensitivity has also become apparent in several large clinical trials, where the methods have continuously failed as robust clinical endpoints. Due to this, the hunt for a sensitive and reproducible method for adequate assessment of the small nerve fibres have begun. Amongst several interesting methods, two have gained particular interest (corneal confocal microscopy and skin biopsies with quantification of intra-epidermal nerve fibre density), due to their diverse strengths, although clinical application is currently limited to a few specialized sites. Furthermore, both methods suffer several inherent issues including that fact that they only provide information about the structure of the nerves and not the function.
In this study, we will therefore combine established gold standards for early detection of structural changes to small nerve fibres in diabetic peripheral neuropathy with cutting-edge, experimental techniques for measuring the function of the same nerve fibres. Furthermore, we will also evaluate several advanced technologies as an alternative to the current clinical standard for large fibre evaluation (biothesiometry).
Study objectives
* To establish a prospective cohort for long-term follow-up for early detection of the development of diabetic peripheral neuropathy
* To evaluate alternative methods for screening for diabetic peripheral neuropathy in a clinical setting
* To evaluate measurements of small nerve fibre function against methods for small nerve fibre structure
Methods
A prospective, long-term, follow-up, cohort study running from 01.04.2022-31.12.2029. The study will consist of two different, yet aligned, sub-studies:
1. An observational, cohort study consisting of a random sample of up to 1,000 persons with diabetes (any type) and neuropathy at any stage, entering the outpatient clinic at Steno Diabetes Center North Denmark/Department of Endocrinology, Aalborg University Hospital.
2. A smaller, observational, cohort study consists of 100-200 persons with type 1 diabetes and no clinically detectable neuropathy.
The first study will aim to evaluate alternative screening methods to be used in clinical practice, while it will also be used to identify persons eligible to participate in the second study.
The second study will aim to preform deep-sensory phenotyping of people without established diabetic peripheral neuropathy using methods evaluating both structure and function of small nerve fibers. The cohort will be followed from inclusion and evaluated once yearly to see if they are progressing. Ultimately, this cohort will be used to retrospectively evaluate, if any, or a combination of, the used experimental methodology can predict, who develops diabetic peripheral neuropathy, and who doesn't.
Participants from either of the two studies will be informed about the trial and their expected outcomes both written and vocally. Participants will follow their usual clinical control for diabetes and complication-screening (including usual foot care and neuropathy screening), and the enhanced screening performed in this study will therefore be an addition to clinical standard. No interventions will be made.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 1 diabetes without known peripheral neuropathy
People with type 1 diabetes without known peripheral neuropathy with "limited" diabetes duration
Skin biopsies with quantification of intra-epidermal nerve fibre density
Skin biopsy
Perception Threshold Tracking
Transcutaneous stimulation of large and small nerve fibres using weak electrical currents
Thermal perception thresholds
Heat and cold perception thresholds
Corneal confocal Microscopy
Corneal nerve fibre density, corneal nerve fibre length, corneal nerve branch density
MRI
Functional and structural MRI pictures of peripheral nerves and CNS
Nerve conduction studies
Nerve conduction and amplitude of Sural nerve
Composite scores and questionnaires
Composite scores and questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skin biopsies with quantification of intra-epidermal nerve fibre density
Skin biopsy
Perception Threshold Tracking
Transcutaneous stimulation of large and small nerve fibres using weak electrical currents
Thermal perception thresholds
Heat and cold perception thresholds
Corneal confocal Microscopy
Corneal nerve fibre density, corneal nerve fibre length, corneal nerve branch density
MRI
Functional and structural MRI pictures of peripheral nerves and CNS
Nerve conduction studies
Nerve conduction and amplitude of Sural nerve
Composite scores and questionnaires
Composite scores and questionnaires
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with diabetes (of any type)
* No clinically established diabetic peripheral neuropathy at inclusion
Exclusion Criteria
* Chemotherapy (prior or within study period) or experimental medicine
* Severe vitamin deficiencies
* Inability to understand or comply with the examinations
* Planned or likely discontinuation of care at Aalborg University Hospital
* Known hematologic disorders resulting in a markedly reduced ability to stop small bleedings
* Severe limb ischemia
* Active diabetic foot ulcers
* Previous amputations
* Severe skin diseases or diseases known to cause neural damage
* Pregnancy at inclusion
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University
OTHER
University of Aarhus
OTHER
Aalborg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johan Bovbjerg Røikjer
Primary Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Vestergaard, PhD
Role: STUDY_CHAIR
Steno Diabetes Center North Denmark
Johan M Røikjer, PhD
Role: PRINCIPAL_INVESTIGATOR
Steno Diabetes Center North Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aalborg University Hospital
Aalborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Johan Røikjer, MD, PhD
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Steno Diabetes Center North Denmark
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20220013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.